These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7524924)

  • 1. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Takano K; Asakawa-Yasumoto K; Shizume K; Demura H
    Endocr J; 1993 Feb; 40(1):111-9. PubMed ID: 7524924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
    Daughaday WH; Trivedi B; Baxter RC
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
    Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
    Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
    Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
    Daughaday WH; Kapadia M
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
    Zapf J; Schmid C; Guler HP; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch ER
    J Clin Invest; 1990 Sep; 86(3):952-61. PubMed ID: 1697608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of serum big-insulin-like growth factor (IGF)-II and IGF binding proteins in two patients with extrapancreatic tumor hypoglycemia, using a combination of Western blotting methods.
    Christofilis MA; Remacle-Bonnet M; Atlan-Gepner C; Garrouste F; Vialettes B; Fuentes P; Guidicelli R; Pommier G
    Eur J Endocrinol; 1998 Sep; 139(3):317-22. PubMed ID: 9758443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
    Shapiro ET; Bell GI; Polonsky KS; Rubenstein AH; Kew MC; Tager HS
    J Clin Invest; 1990 May; 85(5):1672-9. PubMed ID: 2159026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
    van Doorn J; van de Hoef W; Dullaart RP
    Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
    Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
    van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
    Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
    Tally M; Eriksson U; Thorén M; Brismar K; Hall K
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II?
    Widmer U; Zapf J; Froesch ER
    J Clin Endocrinol Metab; 1982 Nov; 55(5):833-9. PubMed ID: 6749876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
    Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
    Zapf J; Futo E; Peter M; Froesch ER
    J Clin Invest; 1992 Dec; 90(6):2574-84. PubMed ID: 1281841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
    van Doorn J; Hoogerbrugge CM; Koster JG; Bloemen RJ; Hoekman K; Mudde AH; van Buul-Offers SC
    Clin Chem; 2002 Oct; 48(10):1739-50. PubMed ID: 12324491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia.
    Zapf J
    Horm Res; 1994; 42(1-2):20-6. PubMed ID: 7525443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.